KBio


KBio aims to create a new generation of biologics using its plant-based platform that has demonstrated the ability to create drug candidates at a fraction of the time and cost of conventional platforms. The Company is focused on developing novel product candidates in two core areas: 1) Antibody ther... Read more

Employees

11-50

Links


Org chart

Patrick Doyle
Chief Executive Officer
Collapse
Matt Best
Sr. Staff Engineer
Jason Morris
Senior Scientist
Laura Thomas
Process Development and Clinical Manufacturing Scientist
Elena Alessandra Federzoni
Drug Discovery & Development - Biologics